Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00247611 · ClinicalTrials.gov registry record · Phase 2
Improving Treatment Adherence in HIV-Infected Individuals
A Phase 2 study, sponsored by University of Connecticut.
- Completed
- Registry status
- Phase 2
- Development phase
- 594
- Enrollment target
NCT00247611 is a Phase 2 study that has completed, run by University of Connecticut. The registered enrollment target is 594 participants.
The verdict
NCT00247611, a Phase 2 study, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 594 participants
- Enrollment target
Study Summary
This study will develop and evaluate the efficacy of an individualized, interactive, computer software program delivered in conjunction with clinical care in increasing and supporting antiretroviral therapy adherence in HIV-infected individuals.
Interventions
- OTHER Control
- BEHAVIORAL LifeWindows Intervention Sessions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 594 participants |
| Start Date | 2005-10 |
| Est. Completion | 2008-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00247611
The ClinicalTrials.gov registry entry for NCT00247611 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 594 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT00247611 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00247611 about?
NCT00247611 is a clinical study titled "Improving Treatment Adherence in HIV-Infected Individuals". This study will develop and evaluate the efficacy of an individualized, interactive, computer software program delivered in conjunction with clinical care in increasing and supporting antiretroviral therapy adherence in HIV-infected individuals.
What is the current status of trial NCT00247611?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 594 participants. The study started on 2005-10. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00247611?
The interventions under investigation include: Control (OTHER), LifeWindows Intervention Sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT00247611?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.